43 results
Page 2 of 3
10-K/A
lypn 16wt0
28 Apr 23
Annual report (amended)
4:15pm
DEFA14A
zsbpu
8 Dec 22
Additional proxy soliciting materials
8:31am
DEF 14A
i7m8toy
25 Nov 22
Definitive proxy
6:16am
8-K
EX-1.1
69fyqrai0
9 Nov 22
Entry into a Material Definitive Agreement
4:50pm
424B5
e6l3v
9 Nov 22
Prospectus supplement for primary offering
4:29pm
8-K
EX-99.1
y3itunszi0tlz
8 Nov 22
Zymeworks Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:19pm
10-Q
51sr0dv169jatzrn5
8 Nov 22
Quarterly report
4:09pm
8-K
EX-1.1
kyt192yqwj
21 Oct 22
Entry into a Material Definitive Agreement
4:19pm
424B5
26s2yrkne i3
21 Oct 22
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
8kw2ite xi04g
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:26am
424B5
cjygo0iehgq
13 Oct 22
Prospectus supplement for primary offering
4:56pm
8-K12B
EX-10.3
9lg7tfo xa1
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-10.2
6o7znrtguyi5lwm4ej01
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-10.4
fvxzcgajp938ekp
13 Oct 22
Notification of registration of securities
7:24am
424B3
u312zlemt3g c85feoq
2 Sep 22
Prospectus supplement
4:06pm
S-4/A
oqv5ua7p
19 Aug 22
Registration of securities issued in business combination transactions (amended)
4:47pm
425
lqbgbtip 0rhy
15 Jul 22
Business combination disclosure
5:26pm
425
51ygh
15 Jul 22
Business combination disclosure
5:23pm
425
04t08g0s2jif r6nv4x
15 Jul 22
Business combination disclosure
5:21pm